Nestlé Health Science has set out its ambition to become market leader in the new field of personalised healthcare through pioneering science-based nutritional solutions within the next 10 years.
Today, a major component of the new Nestlé Health Science company is Nestlé HealthCare Nutrition, already a recognised leader in the established healthcare nutrition marketplace. Through Nestlé HealthCare Nutrition, the company already has strong credibility amongst healthcare professionals, based on a large portfolio of enteral and oral nutrition products, services and devices which together address a range of acute and chronic conditions.
Nestlé Health Science also has a declared strategy to acquire complementary companies, such as Vitaflo, where product synergies will add value to the overall offer.
Through its venture capital portfolio, the company has a stake in innovative businesses such as CM&D, which is running clinical trials on a nutrition product to reduce high levels of phosphate in people with chronic kidney disease.